How Anavex Life Sciences Corp. stacks up

AVXL · against 588 other Healthcare companies listed in US-listed

Valuation

33/ 100

Below the middle of the pack.

Ranked #254 of 589 · scores higher than 50% of peers

Bars: peers in each 10-point band of the valuation score

75 peers with a valuation score of 30–39, including AVXL · Click a bar to see the companies

Why valuation scores 33?

Weighted metrics compared with all Healthcare companies.

Mainly because of its free cash flow yield and earnings yield, which are weaker than most Healthcare peers.

Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -26.3% vs peer median 0.0%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -11.7% vs peer median 1.5%
Cash exceeds market value plus debt, so EBITDA yield is not meaningful and is left out.

Metric by metric

Position: dot = AVXL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	AVXL	Peer median	Better than	Position among peers	Weight
Earnings yieldHigher is better · 577 reported	-11.7%	-4.3%	33%		30%
EBITDA yieldHigher is better · 578 reported	Not reported	-0.8%	—	—	50%
Free cash flow yieldHigher is better · 553 reported	-26.3%	-2.3%	12%		20%
Book yieldHigher is better · 587 reported	101.1%	25.9%	91%		Context only

A metric that is not reported is left out of the score; the other weights are rescaled.

Ranking by valuation score

Top 5 and the companies ranked around AVXL

Rank	Company	Market cap	Valuation	Overall
1	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	98	80
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	96	97
2	CorMedix Inc.CRMD · US-listed	433M USD	96	81
2	Community Health Systems, Inc.CYH · US-listed	289M USD	96	57
2	InMode Ltd.INMD · US-listed	810M USD	96	69
⋯
254	Atossa Therapeutics, Inc.ATOS · US-listed	23M USD	33
254	ArriVent BioPharma, Inc.AVBP · US-listed	642M USD	33	46
254	Avanos Medical IncAVNS · US-listed	1.2B USD	33
254	Avalo Therapeutics, Inc.AVTX · US-listed	389M USD	33	33
254	Anavex Life Sciences Corp.AVXL · US-listed	111M USD	33
254	BridgeBio Oncology Therapeutics, Inc.BBOT · US-listed	186M USD	33	43
254	Bicycle Therapeutics plcBCYC · US-listed	257M USD	33	55
254	BioAge Labs, Inc.BIOA · US-listed	274M USD	33	57
254	Belite Bio, IncBLTE · US-listed	6.1B USD	33

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…